Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
LacTEST® is an unique oral diagnostic drug for Lactase deficiency (Lactose intolerance) based in a NCE that overcomes current deficiencies of existing diagnostic systems. LacTEST® has obtained marketing authorization in Spain and Germany through a More
Virtual Fly-Over: A New Visualization Technique for Virtual Colonoscopy More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 933 pages - $1,495
Nov 2010 - 324 pages - $1,495
Feb 2012 - 1350 pages - $2,695
Dec 2010 - 30 pages - $500
Apr 2011 - 951 pages - $4,995
Dec 2010 - 41 pages - $500
Mar 2011 - 41 pages - $500
Nov 2011 - 7 pages - $3,835
Jan 2008 - 148 pages - $1,740
Apr 2010 - 510 pages - $2,695
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us